| Target Price | $93.84 |
| Price | $71.79 |
| Potential |
30.71%
register free of charge
|
| Number of Estimates | 5 |
|
5 Analysts have issued a price target Ingevity Corporation 2027 .
The average Ingevity Corporation target price is $93.84.
This is
30.71%
register free of charge
$99.75
38.95%
register free of charge
$85.85
19.58%
register free of charge
|
|
| A rating was issued by 9 analysts: 8 Analysts recommend Ingevity Corporation to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Ingevity Corporation stock has an average upside potential 2027 of
30.71%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion $ | 1.17 | 1.14 |
| 2.71% | 2.71% | |
| EBITDA Margin | 25.54% | 35.23% |
| 3.71% | 37.94% | |
| Net Margin | -14.31% | 16.59% |
| 60.09% | 215.92% |
5 Analysts have issued a sales forecast Ingevity Corporation 2026 . The average Ingevity Corporation sales estimate is
This results in the following potential growth metrics:
5 Analysts have issued an Ingevity Corporation EBITDA forecast 2026. The average Ingevity Corporation EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 Ingevity Corporation Analysts have issued a net profit forecast 2026. The average Ingevity Corporation net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -4.61 | 5.47 |
| 61.06% | 218.66% | |
| P/E | 13.13 | |
| EV/Sales | 3.14 |
5 Analysts have issued a Ingevity Corporation forecast for earnings per share. The average Ingevity Corporation EPS is
This results in the following potential growth metrics and future valuations:
Ingevity Corporation...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Wells Fargo |
Locked
➜
Locked
|
Locked | Feb 27 2026 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | Jan 29 2026 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | Dec 19 2025 |
| BMO Capital |
Locked
➜
Locked
|
Locked | Dec 10 2025 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | Nov 12 2025 |
| BMO Capital |
Locked
➜
Locked
|
Locked | Sep 05 2025 |
| BMO Capital |
Locked
➜
Locked
|
Locked | Aug 07 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Feb 27 2026 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Jan 29 2026 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Dec 19 2025 |
|
Locked
BMO Capital:
Locked
➜
Locked
|
Dec 10 2025 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Nov 12 2025 |
|
Locked
BMO Capital:
Locked
➜
Locked
|
Sep 05 2025 |
|
Locked
BMO Capital:
Locked
➜
Locked
|
Aug 07 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


